A detailed history of Caldwell Trust CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Caldwell Trust CO holds 98 shares of REGN stock, worth $67,963. This represents 0.01% of its overall portfolio holdings.

Number of Shares
98
Previous 98 -0.0%
Holding current value
$67,963
Previous $51.5 Million 7.1%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Sep 22, 2025

BUY
$483.07 - $625.6 $47,340 - $61,308
98 New
98 $51.5 Million
Q1 2025

Sep 23, 2025

BUY
$634.14 - $744.83 $9,512 - $11,172
15 Added 15.31%
113 $71.7 Million
Q1 2024

Sep 24, 2025

SELL
$902.69 - $993.35 $63,188 - $69,534
-70 Reduced 71.43%
28 $27 Million
Q3 2023

Oct 01, 2025

SELL
$692.45 - $844.37 $15,233 - $18,576
-22 Reduced 44.0%
28 $23 Million
Q2 2023

Oct 01, 2025

BUY
$700.03 - $830.35 $3,500 - $4,151
5 Added 11.11%
50 $35.9 Million
Q1 2023

Oct 01, 2025

SELL
$680.49 - $826.97 $36,065 - $43,829
-53 Reduced 54.08%
45 $37 Million
Q4 2022

Oct 01, 2025

BUY
$705.89 - $766.39 $19,764 - $21,458
28 Added 155.56%
46 $33.2 Million
Q3 2022

Oct 01, 2025

SELL
$573.97 - $724.32 $45,917 - $57,945
-80 Reduced 81.63%
18 $12.4 Million
Q2 2022

Oct 01, 2025

SELL
$548.35 - $738.84 $1,645 - $2,216
-3 Reduced 14.29%
18 $10.6 Million
Q1 2022

Oct 01, 2025

SELL
$595.12 - $698.43 $45,824 - $53,779
-77 Reduced 78.57%
21 $14.7 Million
Q2 2021

Oct 02, 2025

BUY
$472.8 - $558.54 $1,418 - $1,675
3 Added 16.67%
21 $11.7 Million
Q1 2021

Oct 02, 2025

SELL
$446.73 - $548.2 $35,738 - $43,856
-80 Reduced 81.63%
18 $8.52 Million
Q4 2020

Oct 02, 2025

SELL
$478.3 - $607.98 $38,264 - $48,638
-80 Reduced 81.63%
18 $8.7 Million
Q2 2020

Oct 02, 2025

SELL
$493.32 - $643.92 $39,465 - $51,513
-80 Reduced 81.63%
18 $11.2 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Caldwell Trust CO Portfolio

Follow Caldwell Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caldwell Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Caldwell Trust CO with notifications on news.